These results highlight the usefulness of the pipeline, validate the results obtained in TCGA and ACRG, and denote the clinical impact of the identified genes, with special emphasis for ANKRD6 and ITIH3 in GC malignancy, recurrence and metastasis. The gene discussed is ANKRD6; the disease is gastric cancer.